Desmoid tumor is a rare benign tumor derived from fibrous sheath or musculoaponeurotic structure. The tumor is benign histologically but considered as malignant clinically because it has high propensity on infiltrative growth with local invasion and tendency to recurrence after local excision. Especially, when this tumor happens to be in the intra-abdomen, the prognosis is worse because it can cause intestinal obstruction, ureter obstruction and, fistula formation. It also can invade major vessels in abdomen. This tumor occurs more frequently in patients with familial adenomatous polyposis (FAP), in post-partume women, and at old surgical incision site. However, in this case, the patient had neither previous surgery nor a FAP history. We report a rare case of the young male patient who presented with an acute abdomen and underwent laparotomy and was found to have an intra-abdominal desmoid tumor with abscess formation.
Abdominal Abscess/diagnosis ; Adult ; Diagnosis, Differential ; Fibromatosis, Abdominal/*diagnosis/pathology/surgery ; Humans ; Male ; Peritoneal Neoplasms/*diagnosis/pathology/surgery ; Tomography, X-Ray Computed

No abstract availble.
Abdominal Abscess/diagnosis/*surgery ; Crohn Disease/etiology/surgery/*therapy ; Humans ; Length of Stay ; Predictive Value of Tests ; Recurrence ; Severity of Illness Index

Pediatric onset Crohn's disease (CD) tends to have complicated behavior (stricture or penetration) than elderly onset CD at diagnosis. Considering the longer duration of the disease in pediatric patients, the accumulative chance of surgical treatment is higher than in adult onset CD patients. Possible operative indications include perianal CD, intestinal stricture or obstruction, abdominal abscess or fistula, intestinal hemorrhage, neoplastic changes and medically untreatable inflammation. Growth retardation is an operative indication only for pediatric patients. Surgery can affect a patient's clinical course, especially for pediatric CD patient who are growing physically and mentally, so the decision should be made by careful consideration of several factors. The complex and diverse clinical conditions hinder development of a systemized treatment algorithm. Therefore, timing of surgery in pediatric CD patients should be determined with individualized approach by an experienced and well organized multidisciplinary inflammatory bowel disease team. Best long-term outcomes will require proactive post-operative monitoring and therapeutic modifications according to the conditions.
Abdominal Abscess ; Adult ; Aged ; Child ; Colorectal Surgery ; Constriction, Pathologic ; Crohn Disease* ; Diagnosis ; Hemorrhage ; Humans ; Inflammation ; Inflammatory Bowel Diseases ; Intestinal Fistula

BACKGROUND/AIMS: This study was conducted to compare the clinical efficacy between surgical and nonsurgical treatments for patients with Crohn's disease-related intraabdominal abscess. METHODS: A retrospective review of medical records was performed for patients admitted to a single institution due to Crohn's disease-related intraabdominal abscess from February, 1996 to February, 2008. Clinical outcomes were compared between surgical and nonsurgical groups in terms of treatment responses and recurrences. RESULTS: A total of 47 episodes of intraabdominal abscesses in 43 patients (12.7%) were identified from 339 patients with Crohn's disease. Of these, initially, 18 cases (38.3%) underwent surgical treatment and 29 (61.7%) were treated medically (antibiotic treatments with or without percutaneous drainage). The overall treatment response rates of surgical and nonsurgical group were 100% versus 89.7% (p=0.11) and recurrence rates were 27.8% versus 30.8% (p=1.00). Three patients in nonsurgical group (10.3%) showed no response to therapy and ultimately received surgical drainages. The median length of hospitalization in nonsurgical group was shorter than in surgical group (12 and 29.5 days, respectively. p=0.02). CONCLUSIONS: Nonsurgical treatment might be as effective as surgical treatment for the treatment of Crohn's disease-related intraabdominal abscess, especially considering shorter hospital stay.
Abdominal Abscess/diagnosis/surgery/*therapy ; Adolescent ; Adult ; Crohn Disease/diagnosis/surgery/*therapy ; Drainage ; Female ; Humans ; Length of Stay ; Male ; Middle Aged ; Predictive Value of Tests ; Recurrence ; Retrospective Studies ; Severity of Illness Index

BACKGROUND/AIMS: p53 is known to play a central role in sensing and signaling for the growth arrest and apoptosis in cells with DNA damage. Mutation of p53 is a frequent event in esophageal squamous cell carcinoma (ESCC). p16 protein binds to cyclin dependent kinase 4 (CDK4) inhibiting the ability of CDK4 to interact with cyclin D1, and stimulates the passage through the G1 phase of cell cycle. We observed the expression patterns and frequencies of p53, p16, and cyclin D1 in esophageal dysplasia and in esophageal squamous cell carcinomas. METHODS: In 15 patients of ESCC, 5 patients of esophageal dysplasia and 5 volunteers with normal esophagus, tissue specimens were taken from esophageal lesions during the operation or endoscopic examination. We used specific monoclonal antibodies for p53 protein, p16INK4 protein and cyclin D1. Immunoreactivity was scored. RESULTS: Mean age of all groups was 66 years old (range 47-93) and men to women ratio was 19:1. p53 mutation was observed in 87% (13/15) of ESCC, in 80% (4/5) of esophageal dysplasia, in 0% (0/5) of normal mucosa (p=0.001). p16 expression was seen in 40% (2/5) of esophageal dysplasia, 27% (4/15) of ESCC and 100% (5/5) of normal mucosa (p=0.016). Cyclin D1 expression was not significantly different among 20% (1/5) of esophageal dysplasia, 53% (8/15) of ESCC and 20% (1/5) of normal mucosa. Either the expression of p53 mutation or the loss of p16 occurred in 80% (4/5) of esophageal dysplasia and in 93% (14/15) of ESCC. CONCLUSIONS: The expression of p53 mutation and the loss of p16 might play a central role in the pathogenesis of esophageal squamous cell carcinoma (ESCC), and contribute to the development of precancerous lesion such as dysplasia. In addition, there is a possibility that the mutations of p53 and p16 silencing would be the early events in ESCC development.
Aged ; Carcinoma, Neuroendocrine/*diagnosis/pathology ; Chromogranin A/analysis/immunology ; Drainage ; Female ; Humans ; Immunohistochemistry ; Liver Abscess/*radiography/surgery ; Liver Neoplasms/*diagnosis/pathology ; Radiography, Abdominal ; Synaptophysin/analysis/immunology ; Tomography, X-Ray Computed

PURPOSE: Fournier's gangrene is a rare and rapidly progressive infection of the genitalia, perineum, and abdominal wall. The mortality rate from this infection ranges from 0 to 67 percent. One of the most important determinants of the overall outcome is early recognition and extensive surgical debridement combined with broad-spectrum antibiotics therapy. The objective of this study was to review the clinical outcomes of 11 consecutive patients who suffered with Fournier's gangrene and the related medical literature to highlight the current status of this disease. METHODS: We retrospectively reviewed the records of 11 patients with the Fournier's gangrene who had been treated at Gyeongsang National University Hospital between March 1995 and March 2005. RESULTS: The mean age was 60 years (range: 38~82), and the male to female ratio was 8 : 3. The most common cause of Fournier's gangrene was perianal abscess (n=4, 36.3%) and the most common disease associated with Fournier's gangrene was diabetes mellitus (n=6, 54.5%). The most common cultured organisms were E. coli and K. pneumoniae. We performed aggressive surgical debridement combined with broad spectrum antibiotics therapy. The number of surgical procedures per patients ranged between 1 and 7 (mean: 2.63). Diverting colostomy was required in 36.3% (n=4) of the cases. Two cases received reconstructive plastic surgery. The mortality rate of 11 patients was 27.2% (n=3) and the cause of death was sepsis. CONCLUSION: Fournier's gangrene is a life-threatening disease, but the mortality rate can be diminished via early diagnosis, aggressive surgical intervention, and the use of broad- spectrum antibiotics.
Abdominal Wall ; Abscess ; Anti-Bacterial Agents ; Cause of Death ; Colostomy ; Debridement ; Diabetes Mellitus ; Early Diagnosis ; Fasciitis, Necrotizing ; Female ; Fournier Gangrene* ; Genitalia ; Humans ; Male ; Mortality ; Perineum ; Pneumonia ; Retrospective Studies ; Sepsis ; Surgery, Plastic